Skip to content

Clairfield advises Scope Fluidics on the sale of its subsidiary Curiosity Diagnostics to Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) acquired all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (WSE NewConnect: SCP), a Warsaw, Poland, based developer of innovative technology solutions for the medical diagnostic and healthcare markets.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, acquired all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (WSE NewConnect: SCP), a Warsaw, Poland, based developer of innovative technology solutions for the medical diagnostic and healthcare markets, for a total consideration of up to US$170 million, consisting of approximately $100 million in cash, and up to $70 million in future milestone payments.

Curiosity Diagnostics, a late-stage, pre-commercial platform company, is in the process of developing a sample-to-answer, rapid diagnostics PCR system for the molecular diagnostics market.

“We are excited to have the Curiosity Diagnostics team join Bio-Rad’s Clinical Diagnostics Group and to work closely together to bring a new generation of rapid PCR systems to market,” said Dara Wright, Bio-Rad’s EVP and President, Clinical Diagnostics Group. “Curiosity’s PCR platform, PCR|ONE, offers a streamlined workflow and rapid turnaround times, and is expected to extend our reach beyond high-complexity labs into near-patient molecular diagnostics labs.”

Scope Fluidics President and co-founder, Professor Piotr Garstecki, added, “Our passion at Scope Fluidics is developing innovative technologies addressing the greatest challenges in global health. The dedicated, entrepreneurial team of highly skilled, specialized personnel of Curiosity Diagnostics is looking forward to further developing the PCR|ONE technology under Bio-Rad’s leadership while we at Scope Fluidics continue to pursue new and current projects in disruptive medical diagnostics.”

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With 70 years of focus on quality and customer service, our products advance the scientific discovery process and improve healthcare. Our customers are universities, research institutions, hospitals, biotechnology and pharmaceutical companies, as well as public health and commercial laboratories including food safety and environmental quality testing facilities. Based in Hercules, California, Bio-Rad has a global network of operations with approximately 7,900 employees worldwide and $2.9 billion in revenues in 2021. For more information, please visit bio-rad.com.

Healthcare

Drapeau Poland Drapeau US

Advisor to the seller

Similar transactions

Weldon Biotech India Private Limited, an Indian manufacturer and distributor of in vitro diagnostic products (IVD), sold its i-chroma brand business (Boditech Med Inc., Korea) to CPC Diagnostics Pvt. Ltd., a leading provider of clinical diagnostic products and services and the Indian subsidiary of Singaporean group Everlife.

Read more

Healthcare

Drapeau India Drapeau Singapore

sold its i-chroma business to

Advisor to the seller

AWS Mittelstandsfonds, a Vienna-based growth equity fund focused on Austrian SMEs, sold its remaining shares in three portfolio companies to Evoco AG, a Zurich-based lower midmarket manager that invests in growth and buyout investments in Western Europe with a focus on the DACH region.

Read more

Healthcare

Drapeau Austria Drapeau Germany Drapeau Switzerland

Sale

Advisor to the seller

NTOC, a Dutch specialist in in the manufacturing of medical decontamination and sterilization cassettes, was sold to Inomed Technology, a portfolio company of Initiative & Finance.

Read more

Healthcare

Drapeau Netherlands Drapeau Switzerland

Sale

Advisor to the seller

Ottobock sold select assets in Freedom Innovations Inc. to Proteor, a France-based international group specialized in prosthetic and orthotic solutions.

Healthcare

Drapeau France Drapeau Germany Drapeau US

Sale

Advisor to the seller

Laboratoires Humeau, a leading distributor of lab equipment in France and Africa, was sold to the French investor Intuitis.

Healthcare

Drapeau France

Sale

Advisor to the seller

Hepro Group, a healthcare technology company, was sold to AddLife. The Hepro Group develops, designs and markets assistive technology for home care and welfare.

Read more

Healthcare

Drapeau Norway Drapeau Sweden

Sale

Advisor to the seller

Handico Finland Oy joined the Finnish Haltija Group Oy, a portfolio company of the Finnish private equity investor Sponsor Capital. Handico represents medical aid brands and offers after-sales services nationwide, serving hospital districts, municipalities, and private care companies.

Energy, cleantech & resources , Healthcare

Drapeau Finland

Sale

Advisor to the sell side

Flèche vers la gauche
Flèche vers la droite